Author
Listed:
- Karina Helena Morais Cardozo
(Division of Research and Development, Fleury Group)
- Adriana Lebkuchen
(Division of Research and Development, Fleury Group)
- Guilherme Gonçalves Okai
(Division of Research and Development, Fleury Group)
- Rodrigo Andrade Schuch
(Division of Research and Development, Fleury Group)
- Luciana Godoy Viana
(Division of Research and Development, Fleury Group)
- Aline Nogueira Olive
(Division of Research and Development, Fleury Group)
- Carolina dos Santos Lazari
(Division of Infectious Diseases, Fleury Group)
- Ana Maria Fraga
(Division of Research and Development, Fleury Group)
- Celso Francisco Hernandes Granato
(Division of Infectious Diseases, Fleury Group)
- Maria Carolina Tostes Pintão
(Division of Research and Development, Fleury Group)
- Valdemir Melechco Carvalho
(Division of Research and Development, Fleury Group)
Abstract
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is pressing public health systems around the world, and large population testing is a key step to control this pandemic disease. Here, we develop a high-throughput targeted proteomics assay to detect SARS-CoV-2 nucleoprotein peptides directly from nasopharyngeal and oropharyngeal swabs. A modified magnetic particle-based proteomics approach implemented on a robotic liquid handler enables fully automated preparation of 96 samples within 4 hours. A TFC-MS system allows multiplexed analysis of 4 samples within 10 min, enabling the processing of more than 500 samples per day. We validate this method qualitatively (Tier 3) and quantitatively (Tier 1) using 985 specimens previously analyzed by real-time RT-PCR, and detect up to 84% of the positive cases with up to 97% specificity. The presented strategy has high sample stability and should be considered as an option for SARS-CoV-2 testing in large populations.
Suggested Citation
Karina Helena Morais Cardozo & Adriana Lebkuchen & Guilherme Gonçalves Okai & Rodrigo Andrade Schuch & Luciana Godoy Viana & Aline Nogueira Olive & Carolina dos Santos Lazari & Ana Maria Fraga & Celso, 2020.
"Establishing a mass spectrometry-based system for rapid detection of SARS-CoV-2 in large clinical sample cohorts,"
Nature Communications, Nature, vol. 11(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-19925-0
DOI: 10.1038/s41467-020-19925-0
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-19925-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.